Trial Profile
A study investigating efficacy of Empagliflozin therapy for 2 weeks in patients with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2016
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Oct 2016 New trial record
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes